FACTANKER · measured, cited, anchored official records connected

Fate Therapeutics, Inc. — Operating Income by Fiscal Year

15 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/6a13b2e1-267f-4ea9-9edb-c7e017db40d7/serie/operating-income

Fiscal yearOperating IncomePeriodEvidence
FY 2025$-147.7M2025-01-01 – 2025-12-31evidence 0001193125-26-073699
FY 2024$-210.3M2024-01-01 – 2024-12-31evidence 0000950170-25-033510
FY 2023$-190.5M2023-01-01 – 2023-12-31evidence 0000950170-24-020158
FY 2022$-308.4M2022-01-01 – 2022-12-31evidence 0000950170-23-005067
FY 2021$-217.0M2021-01-01 – 2021-12-31evidence 0000950170-22-002293
FY 2020$-128.1M2020-01-01 – 2020-12-31evidence 0001564590-21-008086
FY 2019$-100.7M2019-01-01 – 2019-12-31evidence 0001564590-20-008141
FY 2018$-67.1M2018-01-01 – 2018-12-31evidence 0001564590-19-006258
FY 2017$-42.1M2017-01-01 – 2017-12-31evidence 0001564590-18-004394
FY 2016$-32.0M2016-01-01 – 2016-12-31evidence 0001564590-17-004614
FY 2015$-27.8M2015-01-01 – 2015-12-31evidence 0001564590-16-013981
FY 2014$-24.9M2014-01-01 – 2014-12-31evidence 0001047469-15-002070
FY 2013$-89.6M2007-04-27 – 2014-03-31evidence 0001104659-14-038138
FY 2012$-13.6M2012-01-01 – 2012-12-31evidence 0001047469-14-002516
FY 2011$-13.3M2011-01-01 – 2011-12-31evidence 0001047469-14-002516
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

Fate Therapeutics, Inc. — all facts · Revenue · Net Income